Frequent alterations in IDH1/2, FGFR1/2/3, EPHA2, and BAP1 were noted predominantly in ICC, whereas mutations in KRAS, ARID1B, ELF3 and PBRM1 occurred preferentially in ECC. This evidence concerns the gene IDH1 and intrahepatic cholangiocarcinoma.